Shepherd A C, Gohel M S, Hamish M, Lim C S, Davies A H
Imperial Vascular Unit, Imperial College, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK.
Phlebology. 2010 Feb;25(1):38-43. doi: 10.1258/phleb.2009.008091.
A variety of endovenous therapies for the treatment of superficial venous incompetence are currently available. The aim of this study was to evaluate the prevalence of endovenous techniques used by consultant vascular surgeons in the United Kingdom.
An anonymous online survey of 16 multiple choice questions relating to the nature and provision of treatment for varicose veins was devised. Consultant members of the Vascular Society of Great Britain and Ireland were invited to participate by email.
A total of 108/352 (31%) surgeons completed the survey. The majority offered surgery as the first-line treatment for primary great saphenous vein (GSV) and small saphenous vein (SSV) incompetence (69% and 74%, respectively). Endovenous procedures were offered as first-line treatment by 32/108 (29.6%) for GSV reflux, 36/51 (70.6%) surgeons performed these under local anaesthetic and 21/51 (41.2%) were performed as an outpatient procedure. The most important factor influencing treatment decisions was considered to be patient preference by 77/108 (71.3%) surgeons, although 48/61 (78.7%) respondents were restricted by primary care trusts with regard to endovenous treatments, and 33/108 (30.6%) offered different treatments to private patients.
Traditional surgery remains the most commonly offered treatment for patients with varicose veins. The provision of endovenous therapies varies greatly, and there are significant differences in local availability regarding these treatments.
目前有多种静脉内治疗方法可用于治疗浅静脉功能不全。本研究的目的是评估英国血管外科顾问医生使用静脉内技术的情况。
设计了一项包含16个与静脉曲张治疗性质和提供方式相关的多项选择题的匿名在线调查。通过电子邮件邀请大不列颠及爱尔兰血管外科学会的顾问成员参与。
共有108/352(31%)名外科医生完成了调查。大多数医生将手术作为原发性大隐静脉(GSV)和小隐静脉(SSV)功能不全的一线治疗方法(分别为69%和74%)。32/108(29.6%)的医生将静脉内治疗作为GSV反流的一线治疗方法,36/51(70.6%)的外科医生在局部麻醉下进行这些治疗,21/51(41.2%)作为门诊手术进行。77/108(71.3%)的外科医生认为影响治疗决策的最重要因素是患者偏好,尽管48/61(78.7%)的受访者在静脉内治疗方面受到初级保健信托的限制,33/108(30.6%)为私人患者提供不同的治疗。
传统手术仍然是静脉曲张患者最常用的治疗方法。静脉内治疗的提供差异很大,这些治疗在当地的可获得性存在显著差异。